Gage Kenneth L, Thomas Kerry, Jeong Daniel, Stallworth Dexter G, Arrington John A
Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, FL.
Cancer Control. 2017 Apr;24(2):172-179. doi: 10.1177/107327481702400209.
The role of imaging in the staging, treatment planning, and ongoing surveillance of patients with head and neck squamous cell carcinoma (HNSCC) continues to evolve. Changes in patient demographics, treatment paradigms, and technology present opportunities and challenges for the management of HNSCC.
The general indications and usage of standard and multimodal cross-sectional imaging in the evaluation and management of HNSCC are reviewed, with an emphasis on incorporating them into treatment pathways. Emerging imaging technologies and methods with a potential near-term impact on HNSCC are discussed.
In general, the complex, multidisciplinary approach to the treatment of advanced HNSCC requires multimodal imaging for adequate treatment planning and follow up. Early-stage disease can often be managed with clinical and endoscopic examinations and a single, cross-sectional imaging modality (eg, computed tomography, magnetic resonance imaging).
Although generalized treatment pathways and guidelines do exist, the literature is rapidly advancing and new radiotracers and evaluation methods are expected to alter both imaging and treatment recommendations in the years to come.
影像学在头颈部鳞状细胞癌（HNSCC）患者的分期、治疗规划及持续监测中的作用不断演变。患者人口统计学特征、治疗模式及技术的变化为HNSCC的管理带来了机遇与挑战。
回顾标准及多模态横断面成像在HNSCC评估与管理中的一般适应证及应用，重点是将其纳入治疗路径。讨论了对HNSCC近期可能产生影响的新兴成像技术和方法。
一般而言，晚期HNSCC的复杂多学科治疗方法需要多模态成像以进行充分的治疗规划和随访。早期疾病通常可通过临床及内镜检查和单一横断面成像模式（如计算机断层扫描、磁共振成像）进行管理。
尽管确实存在通用的治疗路径和指南，但文献发展迅速，预计未来几年新的放射性示踪剂和评估方法将改变成像及治疗建议。
